Although the genomic landscape of NPC has recently been defined, disappointingly only a subset of NPC cases (>10%) was found to harbor immediately druggable somatic events, such as alterations of PIK3CA, FGFR3, and JAK1/2 (3, 15, 16). The gene discussed is FGFR3; the disease is nasopharyngeal carcinoma.